Nantahala Capital Management - Q3 2017 holdings

$2.04 Billion is the total value of Nantahala Capital Management's 82 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 30.2% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$545,302,000
+101.5%
3,680,000
+91.7%
26.74%
+24.6%
SPY BuySPDR S&P 500 ETF TRput$175,861,000
+142.4%
700,000
+133.3%
8.62%
+49.8%
SPY BuySPDR S&P 500 ETF TRcall$150,738,000
+211.7%
600,000
+200.0%
7.39%
+92.7%
SGMS BuySCIENTIFIC GAMES CORPcall$143,969,000
+87.6%
3,140,000
+6.8%
7.06%
+16.0%
EXAS BuyEXACT SCIENCES CORPput$98,952,000
+99.8%
2,100,000
+50.0%
4.85%
+23.5%
RH BuyRHcall$84,384,000
+51.5%
1,200,000
+39.0%
4.14%
-6.3%
AABA SellALTABA INC$67,677,000
+11.7%
1,021,691
-8.2%
3.32%
-31.0%
DLB SellDOLBY LABORATORIES INC$44,543,000
+0.8%
774,397
-14.2%
2.18%
-37.7%
CDXS BuyCODEXIS INC$43,230,000
+22.2%
6,500,679
+0.2%
2.12%
-24.4%
FCAU BuyFIAT CHRYSLER AUTOMOBILES Ncall$39,402,000
+307.4%
2,200,000
+175.0%
1.93%
+151.9%
WRLD BuyWORLD ACCEP CORP DEL$37,040,000
+11.4%
446,861
+0.7%
1.82%
-31.2%
CASH BuyMETA FINL GROUP INC$35,119,000
-9.9%
447,952
+2.3%
1.72%
-44.3%
SODA SellSODASTREAM INTERNATIONAL LTD$33,225,000
+3.8%
500,000
-16.4%
1.63%
-35.8%
LXFR BuyLUXFER HLDGS PLCsponsored adr$29,353,000
+7.7%
2,357,651
+10.7%
1.44%
-33.4%
WRLD NewWORLD ACCEP CORP DELcall$29,012,000350,000
+100.0%
1.42%
FCFS SellFIRSTCASH INC$27,170,000
-23.7%
430,250
-29.6%
1.33%
-52.8%
AKBA SellAKEBIA THERAPEUTICS INC$26,908,000
-12.9%
1,367,947
-36.3%
1.32%
-46.2%
GDEN  GOLDEN ENTMT INC$26,607,000
+17.7%
1,091,3290.0%1.30%
-27.2%
QADA BuyQAD INCcl a$26,483,000
+15.4%
770,973
+7.7%
1.30%
-28.7%
ENT BuyGLOBAL EAGLE ENTMT INC$25,746,000
+31.5%
7,528,066
+36.9%
1.26%
-18.7%
SGMS NewSCIENTIFIC GAMES CORPcl a$22,925,000500,000
+100.0%
1.12%
HRB NewBLOCK H & R INCput$21,184,000800,000
+100.0%
1.04%
TBBK SellBANCORP INC DEL$20,675,000
-27.1%
2,500,000
-33.1%
1.01%
-54.9%
SODA  SODASTREAM INTERNATIONAL LTDcall$19,935,000
+24.2%
300,0000.0%0.98%
-23.2%
AFI BuyARMSTRONG FLOORING INC$19,541,000
+34.8%
1,240,677
+53.8%
0.96%
-16.7%
HTZGQ BuyHERTZ GLOBAL HLDGS INCcall$17,888,000
+211.1%
800,000
+60.0%
0.88%
+92.3%
PETS BuyPETMED EXPRESS INCput$13,260,000
+63.3%
400,000
+100.0%
0.65%
+0.9%
BPI SellBRIDGEPOINT ED INC$12,275,000
-40.3%
1,278,682
-8.2%
0.60%
-63.1%
ARQL BuyARQULE INC$11,366,000
-10.5%
10,239,751
+0.0%
0.56%
-44.7%
JMBA BuyJAMBA INC$11,266,000
+53.2%
1,303,929
+38.1%
0.55%
-5.5%
ORM SellOWENS RLTY MTG INC$11,142,000
+1.5%
611,878
-5.5%
0.55%
-37.3%
MDCO  MEDICINES COcall$11,112,000
-2.6%
300,0000.0%0.54%
-39.8%
QURE BuyUNIQURE NV$10,751,000
+56.8%
1,119,883
+1.1%
0.53%
-3.1%
OSPRU NewOSPREY ENERGY ACQUISITION COunit 07/21/2022$9,960,0001,000,000
+100.0%
0.49%
AVXS  AVEXIS INCput$9,673,000
+17.7%
100,0000.0%0.47%
-27.3%
ONDK  ON DECK CAP INC$9,335,000
+0.2%
1,999,0200.0%0.46%
-38.0%
CGNT BuyCOGENTIX MED INC$9,318,000
+47.3%
3,639,853
+0.2%
0.46%
-9.0%
ASCMA BuyASCENT CAP GROUP INC$9,043,000
+336.6%
693,504
+414.4%
0.44%
+170.1%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$7,902,000
+28.8%
1,602,903
+0.6%
0.39%
-20.5%
SHLDQ  SEARS HLDGS CORPcall$7,300,000
-17.6%
1,000,0000.0%0.36%
-49.1%
GME  GAMESTOP CORP NEWput$6,198,000
-4.4%
300,0000.0%0.30%
-40.9%
DLB NewDOLBY LABORATORIES INCcall$5,752,000100,000
+100.0%
0.28%
BPI NewBRIDGEPOINT ED INCcall$5,280,000550,000
+100.0%
0.26%
NATR BuyNATURES SUNSHINE PRODUCTS IN$5,187,000
+24.7%
510,989
+62.8%
0.25%
-23.0%
LINC SellLINCOLN EDL SVCS CORP$5,075,000
-22.0%
2,029,877
-3.3%
0.25%
-51.7%
CCXI BuyCHEMOCENTRYX INC$5,029,000
-11.2%
677,779
+12.0%
0.25%
-45.1%
FNTE NewFINTECH ACQUISITION CORP II$4,900,000499,998
+100.0%
0.24%
SHOS BuySEARS HOMETOWN & OUTLET STOR$4,016,000
+42.3%
1,575,051
+50.7%
0.20%
-12.1%
TWMC SellTRANS WORLD ENTMT CORP$3,642,000
+24.7%
1,820,939
-0.2%
0.18%
-22.8%
ELVT SellELEVATE CREDIT INC$3,647,000
-26.3%
596,900
-4.5%
0.18%
-54.5%
EMMS  EMMIS COMMUNICATIONS CORP$3,629,000
+15.7%
1,092,9510.0%0.18%
-28.5%
DVD  DOVER MOTORSPORTS INC$3,538,000
-2.4%
1,725,7890.0%0.17%
-39.9%
CRMT BuyAMERICAS CAR MART INC$3,469,000
+5.9%
84,348
+0.2%
0.17%
-34.6%
TAXA BuyLIBERTY TAX INCcl a$3,358,000
+1379.3%
233,198
+1233.2%
0.16%
+816.7%
RLGT  RADIANT LOGISTICS INC$3,273,000
-1.3%
616,4000.0%0.16%
-39.2%
TLYS NewTILLYS INCcl a$2,689,000224,239
+100.0%
0.13%
STRM  STREAMLINE HEALTH SOLUTIONS$2,588,000
+37.4%
1,760,2970.0%0.13%
-14.8%
UTI  UNIVERSAL TECHNICAL INST INC$2,318,000
-2.8%
667,9460.0%0.11%
-39.7%
DNOW NewNOW INC$2,072,000150,000
+100.0%
0.10%
DDE BuyDOVER DOWNS GAMING & ENTMT I$1,627,000
+1.1%
1,579,641
+9.0%
0.08%
-37.5%
MFCB NewMFC BANCORP LTD$1,483,000157,930
+100.0%
0.07%
PTIE BuyPAIN THERAPEUTICS INC$1,413,000
-1.9%
347,053
+0.0%
0.07%
-39.5%
LEE BuyLEE ENTERPRISES INC$1,034,000
+207.7%
470,000
+165.4%
0.05%
+88.9%
EPM SellEVOLUTION PETROLEUM CORP$940,000
-79.4%
130,615
-76.8%
0.05%
-87.3%
FNTEW NewFINTECH ACQUISITION CORP II*w exp 01/19/202$317,000249,999
+100.0%
0.02%
RBCAA  REPUBLIC BANCORP KYcl a$287,000
+9.1%
7,3710.0%0.01%
-33.3%
MFCB ExitMFC BANCORP LTD$0-337,978
-100.0%
-0.05%
FALC ExitFALCONSTOR SOFTWARE INC$0-2,841,368
-100.0%
-0.06%
FBK ExitFB FINL CORP$0-50,000
-100.0%
-0.14%
EZPW ExitEZCORP INCcl a non vtg$0-386,494
-100.0%
-0.24%
STRL ExitSTERLING CONSTRUCTION CO INC$0-257,604
-100.0%
-0.27%
FNTEU ExitFINTECH ACQUISITION CORP IIunit 99/99/9999$0-499,998
-100.0%
-0.41%
CTRN ExitCITI TRENDS INC$0-293,206
-100.0%
-0.49%
CCN ExitCARDCONNECT CORP$0-675,926
-100.0%
-0.81%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings